Detailansicht

Wissensnetz

Person

Anna Jauch

Name	Anna Jauch
Ort	Heidelberg (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	Prof. Dr. sc. hum.
Variante	A. Jauch Anna Sophia Jauch A. S. Jauch
Beziehung	Universität Heidelberg. Institut für Humangenetik (01/1997-) Universität Heidelberg. Medizinische Fakultät (Lehrbeauftragte) (11/2005-) Molekularbiologie (Thema)
Datensatztyp	Person
GND-Nummer	1025525140
Datensatz-ID	1025525140
Beteiligt an alle anzeigen Characterisation of the novel spontaneously immortalized and invasively growing human skin keratinocyte line HaSKpw Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma Selective elimination of immunosuppressive T cells in patients with multiple myeloma Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients Autophagic cell death restricts chromosomal instability during replicative crisis Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma Drug-perturbation-based stratification of blood cancer Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE : a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease Darstellung ganzer Chromosomen und chromosomaler Subregionen bei Mensch und Primaten mittels nicht-radioaktiver in situ Hybridisierungstechniken

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Anna Jauch

Characterisation of the novel spontaneously immortalized and invasively growing human skin keratinocyte line HaSKpw

Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities

Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma

Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma

Selective elimination of immunosuppressive T cells in patients with multiple myeloma

Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone

Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial

Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma

Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial

Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients

Autophagic cell death restricts chromosomal instability during replicative crisis

Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors

Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance

Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma

Drug-perturbation-based stratification of blood cancer

Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology

Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome

Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study

Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome

Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

Darstellung ganzer Chromosomen und chromosomaler Subregionen bei Mensch und Primaten mittels nicht-radioaktiver in situ Hybridisierungstechniken